Online citations, reference lists, and bibliographies.
← Back to Search

Synthesis, Characterization Of α-amino Acid Schiff Base Derived Ru/Pt Complexes: Induces Cytotoxicity In HepG2 Cell Via Protein Binding And ROS Generation.

A. Alsalme, Sameen Laeeq, S. Dwivedi, M. Khan, Khalid A Al Farhan, J. Musarrat, Rais Ahmad Khan
Published 2016 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We have synthesized two new complexes of platinum (1) and ruthenium (2) with α-amino acid, l-alanine, and 2,3-dihydroxybenzaldehyde derived Schiff base (L). The ligand and both complexes were characterized by using elemental analysis and several other spectroscopic techniques viz; IR, (1)H, (13)C NMR, EPR, and ESI-MS. Furthermore, the protein-binding ability of synthesized complexes was monitored by UV-visible, fluorescence and circular dichroism techniques with a model protein, human serum albumin (HSA). Both the PtL2 and RuL2 complexes displayed significant binding towards HSA. Also, in vitro cytotoxicity assay for both complexes was carried out on human hepatocellular carcinoma cancer (HepG2) cell line. The results showed concentration-dependent inhibition of cell viability. Moreover, the generation of reactive oxygen species was also evaluated, and results exhibited substantial role in cytotoxicity.
This paper references
Chem
T. C. Johnstone (2016)
10.1016/b978-0-12-384931-1.00003-9
C
J. Lackie (2013)
10.1007/BF01666038
A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90)
E. Borenfreund (1985)
10.1016/j.colsurfb.2014.06.064
Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells.
S. Dwivedi (2014)
Coord
P. A. Vigato (2004)
Interdiscipl
B. Rosenberg (1978)
10.1039/C5RA07333B
A multifunctional molecular entity CuII–SnIV heterobimetallic complex as a potential cancer chemotherapeutic agent: DNA binding/cleavage, SOD mimetic, topoisomerase Iα inhibitory and in vitro cytotoxic activities
S. Tabassum (2015)
10.1016/J.MOLSTRUC.2012.07.021
Synthesis, characterization, DNA interaction and in vitro cytotoxicity activities of ruthenium(II) Schiff base complexes
S. Sathiyaraj (2012)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1039/B100163I
Mononuclear and dinuclear ruthenium(II)/(III) salicylates incorporating azoimine functionalities as ancillary ligands. Synthesis, spectroscopic and electron-transfer properties
R. Samanta (2001)
10.1016/J.CCR.2015.11.004
New trends in platinum and palladium complexes as antineoplastic agents
M. Fanelli (2016)
Advances in Protein Chem
D. C. Carter (1994)
10.1021/BI00394A013
Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA.
A. Wolfe (1987)
10.1007/s10565-007-9003-4
Vanadate-induced cell death is dissociated from H2O2 generation
M. Capella (2007)
Photobiol
X.-B. Fu (2014)
in Dewey
M. R. Eftink (1991)
10.1039/c3dt51209f
Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα.
S. Tabassum (2013)
Eur
K.-B. Huang (2013)
10.1038/222385A0
Platinum Compounds: a New Class of Potent Antitumour Agents
Barnett Rosenberg (1969)
10.1039/c2mt20091k
Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.
I. León (2012)
10.2307/3103261
The precious metals of medicine
G. Jenkins (1975)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1016/j.saa.2012.03.035
Studies on synthesis, characterization, DNA interaction and cytotoxicity of ruthenium(II) Schiff base complexes.
G. Raja (2012)
10.1006/ABBI.1993.1222
Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells.
J. Royall (1993)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
10.1021/acs.chemrev.5b00597
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
Timothy C Johnstone (2016)
10.1016/j.ejmech.2014.10.076
Mannich bases in medicinal chemistry and drug design
G. Roman (2015)
Curr
C. G. Hartinger (2008)
10.1179/030801878791926119
Platinum Complexes for the Treatment of Cancer
B. Rosenberg (1978)
Chem
W. R. Ware (1962)
10.1016/S0065-3233(08)60640-3
Structure of serum albumin.
D. Carter (1994)
Biochem
S. Das (2010)
10.1016/B978-0-7020-7222-2.00022-6
V
M. Millodot (2018)
10.1039/B001663M
Ruthenium(II)/(III) bipyridine heterochelates incorporating phenolato imine functionalities. Synthesis, crystal structure, spectroscopic and electron-transfer properties and solution reactivities
S. Chakraborty (2000)
Inorg
L.-J. Li (2014)
Coord
M. Fanelli (2016)
Photobiol
S. Tabassum (2012)
10.1016/S0009-2797(98)00075-1
Spectroscopy features of the binding of polyene antibiotics to human serum albumin.
D. Romanini (1998)
Toxicol
M. A. Siddiqui (2008)
Cell Biol
Y. Qin (2008)
Str
A. Sułkowska (2006)
10.1016/j.tiv.2008.07.001
Influence of cytotoxic doses of 4-hydroxynonenal on selected neurotransmitter receptors in PC-12 cells.
M. A. Siddiqui (2008)
10.1039/c5dt00770d
Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Imtiyaz Yousuf (2015)
10.2174/092986708785908978
Carbohydrate-metal complexes and their potential as anticancer agents.
Christian G Hartinger (2008)
10.1039/c5dt03919c
Metal-based drugs that break the rules.
C. Allardyce (2016)
Principles of Fluorescence Spectroscopy, 2nd ed
J. R. Lackowicz (1999)
Soc
S. Chakraborty (2000)
10.1016/j.jphotobiol.2014.04.024
Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies.
F. Arjmand (2014)
10.1016/j.jphotobiol.2014.04.019
Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities.
G. Prakash (2014)
10.1016/J.ICA.2014.04.036
Synthesis, characterization and cytotoxicity studies of platinum(II) complexes with reduced amino acid ester Schiff-bases as ligands
L. Li (2014)
Cancer Therap
T. Boulikas (2007)
10.1016/J.MOLSTRUC.2006.01.002
Paracetamol and cytarabine binding competition in high affinity binding sites of transporting protein.
A. Sułkowska (2006)
10.1016/j.jinorgbio.2009.09.017
Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.
Sangeeta Das (2010)
Cell Biol
M.A.M. Capella (2007)
In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
K. Wosikowski (2003)
10.1007/978-1-4684-0796-9_10
Noble metal complexes in cancer chemotherapy.
B. Rosenberg (1977)
10.1016/j.bmc.2013.04.037
An insight into synthetic Schiff bases revealing antiproliferative activities in vitro.
K. Sztanke (2013)
Dalton Trans
I. Yousuf (2015)
Spectrochim
G. Raja (2012)
10.1039/B513476E
Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
K. Thompson (2006)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
Soc
R. Samanta (2001)
10.1016/j.jinorgbio.2013.10.006
Stabilization of G-quadruplex DNA and inhibition of telomerase activity studies of ruthenium(II) complexes.
Q. Li (2014)
Clin
K. Wosikowski (2003)
10.1016/j.ejmech.2013.01.055
Platinum(II) complexes with mono-aminophosphonate ester targeting group that induce apoptosis through G1 cell-cycle arrest: synthesis, crystal structure and antitumour activity.
Ke-Bin Huang (2013)
10.1515/9783111548050-024
M
M. Sankar (1824)
10.1016/j.jphotobiol.2012.05.021
Synthesis, characterization and interaction studies of copper based drug with Human Serum Albumin (HSA): spectroscopic and molecular docking investigations.
S. Tabassum (2012)
10.1039/c0dt00292e
The status of platinum anticancer drugs in the clinic and in clinical trials.
Nial J. Wheate (2010)
10.1016/J.JORGANCHEM.2014.09.036
Benzyl-substituted carbene–metal complexes: Potential for novel antibiotics and anticancer drugs?
M. Tacke (2015)
10.1016/j.cellbi.2007.08.028
Dihydrorhodamine 123 is superior to 2,7‐dichlorodihydrofluorescein diacetate and dihydrorhodamine 6G in detecting intracellular hydrogen peroxide in tumor cells
Y. Qin (2008)
Colloids Surf
S. Dwivedi (2014)
Adv
B. Rosenberg (1977)
10.1021/acs.inorgchem.5b01647
Chiral Platinum(II) Complexes Featuring Phosphine and Chloroquine Ligands as Cytotoxic and Monofunctional DNA-Binding Agents.
Wilmer Villarreal (2015)
Dalton Trans
S. Tabassum (2013)
10.1023/A:1015396825274
Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin
Victor Tuan Giam Chuang (2004)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.1016/J.JPHOTOCHEM.2013.12.002
Synthesis, characterization, DNA binding and cleavage, HSA interaction and cytotoxicity of a new copper(II) complex derived from 2-(2′-pyridyl)benzothiazole and glycylglycine
Xia-Bing Fu (2014)
10.1016/0022-1759(83)90303-4
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
T. Mosmann (1983)
Photobiol
F. Arjmand (2014)
Bioorg
K. Sztanke (2013)
10.1039/C5RA25071D
In vivo assessment of newly synthesized achiral copper(II) and zinc(II) complexes of a benzimidazole derived scaffold as a potential analgesic, antipyretic and anti-inflammatory
M. Alajmi (2016)
10.1002/ANIE.199720851
Site specific photocleavage of proteins
C. Kumar (1997)
Angew
C. V. Kumar (1997)
10.1016/J.CCT.2003.09.003
The challenge of cyclic and acyclic schiff bases and related derivatives
P. A. Vigato (2004)
Biochem
Q. Li (2014)
Dalton Trans
C. S. Allardyce (2016)
Photobiol
G. Prakash (2014)
10.1021/J100809A020
OXYGEN QUENCHING OF FLUORESCENCE IN SOLUTION: AN EXPERIMENTAL STUDY OF THE DIFFUSION PROCESS
W. R. Ware (1962)
Dalton Trans
K. H. Thompson (2006)
Arch
J. A. Royall (1993)
10.1007/978-1-4757-9513-4
Biophysical and Biochemical Aspects of Fluorescence Spectroscopy
T. Dewey (1991)
Pharmceut
V.T.G. Chuang (2002)



This paper is referenced by
10.1016/J.MOLSTRUC.2016.06.034
Effective DNA binding and cleaving tendencies of malonic acid coupled transition metal complexes
N. Pravin (2016)
Synthesis of ruthenium ( II ) complexes and investigation of their antiproliferative mechanism against osteosarcoma cells
Longyi Xiao (2018)
10.35378/gujs.654598
Antioxidant and Cytotoxic Activity Studies in Series of Higher Amino Acid Schiff Bases
Ö. Özdemir (2020)
Preparation and bioactivities of Cu(II) and Ni(II) complexes containing amino acid-derived schiff bases
Nur Fatihah Abas (2017)
10.1002/aoc.5269
Syntheses, characterizations, crystal structures, DFT/TD‐DFT, luminescence behaviors and cytotoxic effect of bicompartmental Zn (II)‐dicyanamide Schiff base coordination polymers: An approach to apoptosis, autophagy and necrosis type classical cell death
D. Majumdar (2020)
10.1007/s11696-019-00986-5
Synthesis, characterization and antibacterial activity studies of new 2-pyrral-L-amino acid Schiff base palladium (II) complexes
E. A. Nyawade (2020)
10.1016/J.POLY.2019.01.028
Studies on the synthesis, characterization, cytotoxic activities and plasmid DNA binding of platinum(II) complexes having 2-subsituted benzimidazole ligands
M. Gozelle (2019)
10.1080/07391102.2018.1528180
Evaluation of (ɳ6-p-cymene) ruthenium diclofenac complex as anticancer chemotherapeutic agent: interaction with biomolecules, cytotoxicity assays
Rais Ahmad Khan (2018)
10.15406/mojt.2018.04.00105
Evaluation of cellular toxicity in Hep G2 cell and endothelial cells on different medical biopolymer supports
E. T. Fokunang (2018)
10.1080/00958972.2017.1349313
Review: recent advances and future development of metal complexes as anticancer agents
P. Jia (2017)
10.1080/00958972.2020.1824293
Biological response of Schiff base metal complexes incorporating amino acids – a short review
A. Arunadevi (2020)
10.1002/jbt.22510
Reduced amino acid Schiff base containing ruthenium(III) complexes: Synthesis, characterization, DNA interaction, and in vitro cytotoxicity.
Zhaokuo Zhang (2020)
10.1002/AOC.4150
Supramolecular interaction of transition metal complexes with albumins and DNA: Spectroscopic methods of estimation of binding parameters
Polina А. Galkina (2018)
10.1002/aoc.5687
Recent advances in anticancer ruthenium Schiff base complexes
Shazia Parveen (2020)
10.1016/j.molstruc.2019.127590
Molecular docking and inhibitory effects of a novel cytotoxic agent with bovine liver catalase
S. Shahraki (2020)
Semantic Scholar Logo Some data provided by SemanticScholar